Correction to Lancet Child Adolesc Health 2021; 5: 852-61

No authors listed

Free article

Published Erratum

No authors listed. Lancet Child Adolesc Health. 2022 Feb.

Free article

. 2022 Feb;6(2):e5.

doi: 10.1016/S2352-4642(21)00399-0. Epub 2021 Dec 20.

No abstract available

Erratum for

Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S; KIDCARE Multicenter Study Group. Burns JC, et al. Lancet Child Adolesc Health. 2021 Dec;5(12):852-861. doi: 10.1016/S2352-4642(21)00270-4. Epub 2021 Oct 27. Lancet Child Adolesc Health. 2021. PMID: 34715057 Clinical Trial.